pelvic tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient is fully informed and voluntarily signed a written informed consent form prior to the start of any research-related procedures; 2. Age 18-75 years old; 3. Patients diagnosed with cervical cancer by pathology; 4. The patient is in good general condition with a KPS > 70 points; 5. Life expectancy is at least 6 months. 6. The function of each organ is basically normal (in the absence of continuous supportive treatment, the results of laboratory tests within one week prior to enrollment): neutrophils > 1.5 × 109 / L, platelets > 100 × 109 / L, hemoglobin > 9.0g/dl, normal bilirubin or <1.5×ULN, ALT, AST<2.5×ULN, serum creatinine 1.5×ULN, normal stool.
Exclusion criteria
Exclusion criteria: 1. The general condition is poor, KPS <70 points; 2. Pregnant women, lactating women; 3. a second primary tumor; 4. suffering from chronic digestive diseases, such as peptic ulcer, inflammatory bowel disease, severe liver disease and other patients; 5. Long-term use of immunosuppressive agents or antibiotics within 1 month prior to enrollment; 6. Accept other clinical trial patients at the same time; 7. Allergic to the test sample or obvious gastrointestinal symptoms such as intolerance; 8. Patients diagnosed with HIV/AIDS or liver disease; 9. Patients who depend on controlled drugs or/and alcohol; 10. Patients undergoing anticoagulant therapy; 11. Patients who refuse to sign an informed consent form; 12. Patients taking antibiotics during follow-up (without the consent or guidance of the competent physician); 13. Patients with irregular eating habits and large changes during follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| D-lactic acid;Plasma diamine oxidase;Plasma endotoxin;Humoral immune function test;Blood routine;Macrophages;Stool routine; | — |
Countries
China
Contacts
Weihai Municipal Hospital